Follistatin-like 1 As a Novel Adipomyokine Related to Insulin Resistance and Physical Activity

Xiaohui Xu,Tingran Zhang,Mani Mokou,Ling Li,Peng Li,Jinlin Song,Hua Liu,Zhiming Zhu,Dongfang Liu,Mengliu Yang,Gangyi Yang

DOI: https://doi.org/10.1210/clinem/dgaa629

2020-01-01

Abstract:BACKGROUND AND AIMS FSTL-1 is considered to be an adipokine or myokine that could be a potential regulator of metabolism. Our purpose is to investigate the relationship between circulating FSTL-1 levels and insulin resistance (IR) in type 2 diabetes mellitus (T2DM) and to identify the regulatory factors. METHODS FSTL-1 expression in C57BL/6J and db/db mice was examined by qRT-PCR and Western blots. Serum FSTL-1 levels were measured by ELISA in 298 patients with T2DM and 202 healthy controls. Changes in the circulating FSTL-1 level were observed during the OGTT, EHC, lipid infusion, acute exercise, and cold-exposure test. RESULTS We found that FSTL-1 protein expression in the adipose tissue of db/db mice was significantly higher than that of WT mice. Importantly, circulating FSTL-1 levels in T2DM and overweight/obese subjects were higher than those in healthy and lean subjects, and was related to HOMA-IR, adiponectin, and obesity- and metabolism-related parameters. In the intervention study, 45 minutes of physical activity was found to significantly increase the circulating FSTL-1 concentration in young, healthy subjects. Further, FSTL-1 protein expression in adipose tissue rose dramatically in response to physical activity in mice. Hyperinsulinemia during EHC and acute elevated FFA induced by lipid infusion resulted in a significant decrease in the circulating FSTL-1 levels. However, no change was found in the circulating FSTL-1 levels in response to the oral glucose challenge or cold exposure test. CONCLUSIONS FSTL-1 may be an adipo-myokine associated with insulin resistance and physical activity, and the circulating FSTL-1 levels are increased in patients with T2DM.